NCT07282574
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with Progressive Multiple Sclerosis (MS), confirmed using a specific set of medical guidelines called the 2017 McDonald criteria
- Your level of physical disability, as measured by a standard MS scoring scale, falls within a moderate range (between 3.0 and 6.0 on this scale — confirm with trial site if unsure of your score)
Who may not be able to join:
- You have had an MS relapse (a flare-up of symptoms) in the 6 months before joining the trial
- Doctors are unable to access a vein in your arm or hand for injections or blood draws
- You have a history of alcohol or drug misuse within the past 5 years, based on the doctor's assessment
- You are unable to have an MRI scan for any reason
- You have a medical reason that prevents you from taking certain medications that must be given alongside the trial treatment (confirm with trial site)
- You have received a treatment called intravenous immunoglobulin (a blood-derived therapy given through a drip) or a blood-filtering treatment called plasmapheresis within the 12 weeks before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Time From Randomization to the First Occurrence of Composite Confirmed Disability Progression (cCPD) Confirmed for at Least 12 Weeks (cCDP12)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.